Langer CJ - Search Results

1

Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.

Langer CJ, Obasaju C, Bunn P, Bonomi P, Gandara D, Hirsch FR, Kim ES, Natale RB, Novello S, Paz-Ares L, Pérol M, Reck M, Ramalingam SS, Reynolds CH, Socinski MA, Spigel DR, Wakelee H, Mayo C, Thatcher N. Langer CJ, et al. J Thorac Oncol. 2016 Dec;11(12):2066-2081. doi: 10.1016/j.jtho.2016.08.138. Epub 2016 Aug 26. J Thorac Oncol. 2016. PMID: 27575423 Free article. Review.

2

Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.

O'Dwyer PJ, Langer CJ, Walczak J, Levy MH, Padavic-Shaller K, Hudes GR, Litwin S, Comis RL. O'Dwyer PJ, et al. Among authors: langer cj. Eur J Cancer. 1991;27(12):1589-93. doi: 10.1016/0277-5379(91)90420-i. Eur J Cancer. 1991. PMID: 1664216

3

Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.

Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R. Langer CJ, et al. Semin Oncol. 1995 Jun;22(3 Suppl 6):64-9. Semin Oncol. 1995. PMID: 7541156 Clinical Trial.

4

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Langer CJ, et al. J Clin Oncol. 1995 Aug;13(8):1860-70. doi: 10.1200/JCO.1995.13.8.1860. J Clin Oncol. 1995. PMID: 7543559 Clinical Trial.

5

An update on North American randomized studies in non-small cell lung cancer.

Bunn PA Jr, Vokes EE, Langer CJ, Schiller JH. Bunn PA Jr, et al. Among authors: langer cj. Semin Oncol. 1998 Aug;25(4 Suppl 9):2-10. Semin Oncol. 1998. PMID: 9728578 Review.

6

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

7

Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer.

Langer CJ. Langer CJ. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):108-16. Semin Radiat Oncol. 1999. PMID: 10210549 Clinical Trial.

8

Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.

Socinski MA, Langer CJ. Socinski MA, et al. Among authors: langer cj. Semin Oncol. 1999 Oct;26(5 Suppl 16):51-61; discussion 71-2. Semin Oncol. 1999. PMID: 10585009 Review.

9

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Among authors: langer cj. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

10

Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan.

Langer CJ. Langer CJ. Oncology (Williston Park). 2001 Jan;15(1 Suppl 1):19-24. Oncology (Williston Park). 2001. PMID: 11221017 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters